A viewpoint, published in The Lancet Public Health, reviewed the evidence base for TB screening and diagnostic strategies in prisons, highlighting promising approaches and knowledge gaps.

To mark World TB Day, RESIST-TB released an overview summarizing the past year's achievements, challenges, and continued progress in the fight against drug-resistant TB.

A new article in the Journal of the International AIDS Society highlights the urgent need for a clear strategy to prevent and treat advanced HIV disease in children and teens.

The International Journal of Tuberculosis and Lung Disease (IJTLD) is the official publication of the International Union Against Tuberculosis and Lung Disease (The Union).

In a recent review published in the Open Forum Infectious Diseases journal, researchers reported on the evolution of multidrug-resistant tuberculosis (MDR-TB) therapy.

University of Otago researchers have discovered new ways to treat antibiotic-resistant strains of tuberculosis (TB), opening the door to new approaches for tackling the disease that kills about 4,000 people a day.

SAN ANTONIO (April 5, 2023) — Texas Biomed scientists have identified a promising way to help fight tuberculosis (TB), a disease that still kills nearly 2 million people annually. The research focuses on a potential host-directed therapy targeting the immune system to bolster the body’s ability to control the infection, a method shown to improve cancer treatments.

On 17 April 2023, the World Health Organization (WHO) will convene a Town Hall for civil society and affected communities in close collaboration with WHO's Civil Society Task Force on TB, on preparations for the upcoming UN High-Level Meeting (UNHLM) on TB.

SEOUL, South Korea, April 4, 2023 /PRNewswire/ -- Standigm, a company using artificial intelligence (AI) technology for drug discovery and development, and Korean non profit research institute Institut Pasteur Korea announced that they have jointly developed new lead compounds effective in treating resistant tuberculosis (TB). The two organizations conducted a technology acceleration grant project supported by the Right Foundation from 2021 to 2022. They achieved encouraging results by combining their core competencies of artificial intelligence (AI) platforms, infectious disease research capabilities and drug discovery technologies. This breakthrough demonstrates that AI technology can effectively address unmet medical needs for low and middle-income countries that tend to have higher than normal rates of resistant TB.

The International Union Against Tuberculosis and Lung Disease compiled and shared facts about TB to dispel some myths, misconceptions, and half-truths getting in the way of ending TB.